Fluorescence anisotropy assay for pharmacological characterization of ligand binding dynamics to melanocortin 4 receptors.
Veiksina. Santa S; Kopanchuk. Sergei S; Rinken. Ago A
Key Findings
- A fluorescence anisotropy assay can track MC4R binding of melanotan‑I analogues in real time.
- Cy3B‑labeled peptide performs better than TAMRA‑labeled peptide (more stable, less buffer‑sensitive, better signal).
- Binding to MC4R is high‑affinity but slow; equilibrium isn’t reached within 3 hours.
Practical Outcomes
- For DIY users, the data suggest that melanotan‑I (NDP‑α‑MSH) binds strongly but slowly to its target, which may influence how often you dose. The improved Cy3B assay isn’t directly usable at home, but it confirms that the peptide’s activity is robust across conditions. No new dosing guidelines or safety data are provided.
Summary
The study shows a new lab test that watches how melanotan‑I‑like peptides stick to the MC4R receptor in real time. Using a brighter, more stable dye (Cy3B) gave clearer results than an older dye (TAMRA). Both peptide versions bound tightly, but they didn’t reach a steady state even after three hours, meaning the interaction is slow.
Abstract
Fluorescence anisotropy assay was implemented for characterization of ligand binding dynamics to melanocortin 4 (MC(4)) receptors. This approach enables on-line monitoring of reactions that is essential for estimation of more correct binding parameters, understanding of ligand binding and its regulation mechanisms, and design of new drugs with desirable properties. Two different red-shifted fluorophore-labeled peptide ligands, Cy3B-NDP-alpha-MSH and TAMRA-NDP-alpha-MSH, were used and compared in assays that monitored their binding to MC(4) receptors in membranes of Sf9 insect cells. The Cy3B dye-labeled ligand exhibited improved performance in assays when compared with the TAMRA-labeled ligand, having higher photostability, insensitivity to buffer properties, and better signal/noise ratio. The binding of both ligands to membranes of Sf9 cells expressing MC(4) receptors was saturable and with high affinity. All studied MC(4) receptor-specific nonlabeled ligands displaced fluoroligands' binding in a concentration-dependent manner with potencies in agreement with their pharmacological activities. On-line monitoring of the reactions revealed that equilibrium of peptide binding was not reached even after 3h. Real-time monitoring of ligand binding dynamics enabled us to find optimal experimental conditions for each particular ligand and an improved estimate of their binding parameters.
Study Information
pubmed
2010
2010-03-17T00:00:00.000Z
10.1016/j.ab.2010.03.022
38
40